Constellation Brands (NYSE: STZ), founded in 1945 by Marvin Sands as Canandaigua Industries, produces and markets beer, wine, and spirits. The company has over 100 brands in its portfolio including Corona, Ruffino, and Svedka Vodka. The company grew through acquisitions and the introduction of its wildly popular Richard's Wild Irish Rose brand of dessert wines. It went public in 1973 and continued acquisitions of popular brands including leading Kosher wine-maker Manischewitz, in 1987. Constellation's most recent investment was in cannabis company Canopy Growth, in 2018 to the tune of $4 billion.
Constellation Brands has grown its business through the acquisitions of premium vintners like Franciscan Vineyards and Opus One and high-grade distillers like Nelson's Green Brier Whiskey and Casa Noble Tequila. On the other end of this practice, the company divests lower-margin and lower-priced wines and spirits, thereby concentrating all its strength on higher-priced labels. This premiumization is limited to the company's Wine and Spirits segment, which records lower sales than its Beer segment. Constellation's other two divisions are Corporate Operations and Canopy -- the Cannabis segment which is currently recording losses.
The company is optimistic about Canopy's offering of THC and CBD infused beverages, which currently hold the market lead in Canada. If they perform anything like Constellation's Corona Hard Seltzers, then the company has a real winner on its hands. The seltzer brand, launched last year, has already gained a 6% U.S. market share without taking sales from other segments in the company. This is no doubt thanks to the company's strong brand loyalty, which it continues to reinforce with its operating paradigm. The beverages are due to launch in the U.S. this year, and not a moment too soon, as the global cannabis beverage market is projected to reach $2.8 billion by 2025.
Constellation is the number one seller of imported beer in the U.S. and beer accounted for 67.3% of the company's total sales in fiscal 2020, with wine comprising 28.4% and spirits, 4.3% of all sales. As per the company's Q3 2021 report, earnings of $3.09 per share beat estimates (for the 12th consecutive time) of $2.41 and were a 44% increase year-over-year (YoY). Additionally, net sales were up 22% to $2.44 billion surpassing projections of $2.27 billion. Beer sales were up 28% to $1.68 billion and wine and spirits sales increased 10% to $760 million.
Adjusted gross profit went up 22.4% YoY to $1.28 billion and adjusted gross profit margin expanded 20 basis points to 52.5%. For fiscal 2021, the company projects depletion, or unit sales, growth of 2 to 4% for its premium Power Brand portfolio after the divestitures of its most recent poor performing brands.
Constellation Brands pays a dividend of $0.75 and recently authorized a $2 billion share repurchase program.
Along with Canopy's Tweed brand cannabis beverages due in the U.S. markets this year, Constellation is also expanding its Corona Seltzer flavor offerings. Moreover, the company will be growing its online presence which it started with the purchase of digitally-native brand Empathy Wines last July. Constellation is expecting to achieve 7 to 9% net sales growth in fiscal 2021.
This is a market-leading adult beverage company that knows what it's doing. Keeping up with trends of premiumization and hard seltzers, as well as having its eye on future developments in the cannabis sector, all while limiting spending on lower-priced and lower-margin products has kept Constellation thriving and will no doubt serve it well in the future.
MyWallSt operates a full disclosure policy. MyWallSt staff currently holds long positions in companies mentioned above. Read our full disclosure policy here.
The Home of Successful Investing.
© 2024 MyWallSt Ltd. All rights reserved.
Services
Social
Company
Support
This website is operated by MyWallSt Ltd (“MyWallSt”). MyWallSt is a publisher and a technology platform, not a registered broker-dealer or registered investment adviser, and does not provide investment advice. All information provided by MyWallSt Limited is of a general nature for information and education purposes, and you should not construe any such information as investment advice. MyWallSt Limited does not take your specific needs, investment objectives or financial situation into consideration, and any investments mentioned may not be suitable for you. You should always carry out your own independent verification of facts and data before making any investment decisions, as we cannot guarantee the accuracy or completeness of any information we publish and any opinions that we publish may be wrong and may change at any time without notice. If you are unsure of any investment decision you should seek a professional financial advisor. MyWallSt Limited is not a registered investment adviser and we do not provide regulated investment advice or recommendations. MyWallSt Limited is not regulated by the Central Bank of Ireland. MyWallSt Limited may provide hyperlinks to web sites operated by third parties. Your use of third party web sites and content, including without limitation, your use of any information, data, advertising, products, or other materials on or available through such web sites, is at your own risk and is subject to the third parties' terms of use.